San Francisco-based Pharos, a hospital quality reporting platform, has secured seed funding of $5 million to enable its reporting to shift to use artificial intelligence. However, the latest round was the largest to date and was led by Felicis Ventures and joined by General Catalyst, Moxxie Ventures and Y Combinator.
Strategic Use of Funds
The funding obtained will address the need to grow Pharos’ engineering talent and broaden the scope of this platform on the support of new clinical quality registers, as well as the improvement of process metric measurements.
About Pharos
Specifically, Pharos is a young company from 2024, initiated by a clinic and AI specialists team and is guided by the CEO, Felix Brann and the CTO, Matthew Jones. At Pharos we focus on automating the clinical quality reporting for hospitals so that they can submit to state and national quality registries without having to manually input data. The platform’s AI-powered solution also automates the extraction of custom process metrics, empowering healthcare quality teams to:
- Discover different process breakdowns that are causing harm to patients.
- Find strategies to reduce mortality of diseases like sepsis or preventing acquisition of infections in the hospital, pressure ulcers, and so on.
Leadership and Expertise
Dr. Alex Clarke has an MD, and completed his PhD in Artificial Intelligence at Imperial College London, which gives Pharos direction in things AI for healthcare.
Pharos has been designed with the goal of eliminating existing limitations on quality reporting and giving hospitals visibility into their processes and performance in order to reimagine quality management in hospitals and bring about tangible betterment of healthcare safety among patients.
**To get all USA Startup news Please Visit – https://growwseed.com/category/usa-startup-funding-news/
